{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:23:08Z","timestamp":1790230988073,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1124\/jpet.118.247668","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T18:00:43Z","timestamp":1526666443000},"page":"349-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["OBE022, an Oral and Selective Prostaglandin F2 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor"],"prefix":"10.1016","volume":"366","author":[{"given":"Oliver","family":"Pohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Chollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Riaposova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sp\u00e9zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lluel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"M\u00e9en","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Lemaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasso","family":"Terzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip R.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gotteland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.247668_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jc.2011-1991","article-title":"The roles of prostaglandin EP 1 and 3 receptors in the control of human myometrial contractility","volume":"97","author":"Arulkumaran","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.118.247668_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(80)90559-1","article-title":"Induction of labor with low-dose prostaglandin F2 alpha and oxytocin","volume":"136","author":"Baxi","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib3","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/humrep\/deu205","article-title":"A first-in-human study of PDC31 (prostaglandin F2\u03b1 receptor inhibitor) in primary dysmenorrhea","volume":"29","author":"B\u00f6ttcher","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1124\/jpet.118.247668_bib4","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/jm200608k","article-title":"Targeting the prostaglandin F2\u03b1 receptor for preventing preterm labor with azapeptide tocolytics","volume":"54","author":"Bourguet","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.247668_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00041552-200001000-00005","article-title":"Prostaglandin receptors: their role in regulating renal function","volume":"9","author":"Breyer","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.118.247668_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.0.1240001","article-title":"Prostaglandins and mechanisms of preterm birth","volume":"124","author":"Challis","year":"2002","journal-title":"Reproduction"},{"key":"10.1124\/jpet.118.247668_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1203\/00006450-200011000-00008","article-title":"The renal hemodynamic effects of ibuprofen in the newborn rabbit","volume":"48","author":"Chamaa","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1124\/jpet.118.247668_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/jpet.103.049395","article-title":"Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2\u2032-methyl[1,1\u2032-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor","volume":"306","author":"Cirillo","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.247668_bib9","doi-asserted-by":"crossref","first-page":"54.e1","DOI":"10.1016\/j.ajog.2007.02.010","article-title":"Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP)","volume":"197","author":"Cirillo","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875397300903010022","article-title":"HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications","volume":"3","author":"Degorce","year":"2009","journal-title":"Curr Chem Genomics"},{"key":"10.1124\/jpet.118.247668_bib11","first-page":"453","article-title":"Renal effects of indomethacin and dopamine in newborn rabbits","volume":"30","author":"Duarte-Silva","year":"1986","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.118.247668_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1471-0528.2005.00658.x","article-title":"Specific PGF(2\u03b1) receptor (FP) antagonism and human uterine contractility in vitro","volume":"112","author":"Friel","year":"2005","journal-title":"BJOG"},{"key":"10.1124\/jpet.118.247668_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1507\/endocrj1954.31.565","article-title":"Study of oxytocin receptor: II. oxytocin and prostaglandin F2 alpha receptors in human myometria and amnion-decidua complex during pregnancy and labor","volume":"31","author":"Fukai","year":"1984","journal-title":"Endocrinol Jpn"},{"key":"10.1124\/jpet.118.247668_bib14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0002-9378(87)80315-0","article-title":"Effects of the antiprogesterone RU 486 on preterm birth in the rat","volume":"157","author":"Garfield","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib15","doi-asserted-by":"crossref","first-page":"25624","DOI":"10.1074\/jbc.M110.115196","article-title":"A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2\u03b1-mediated Rho\/ROCK signaling pathway","volume":"285","author":"Goupil","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.247668_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod.106.051987","article-title":"Regional expression of prostaglandin E2 and F2alpha receptors in human myometrium, amnion, and choriodecidua with advancing gestation and labor","volume":"75","author":"Grigsby","year":"2006","journal-title":"Biol Reprod"},{"key":"10.1124\/jpet.118.247668_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.prostaglandins.2012.02.001","article-title":"PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth","volume":"97","author":"Gruzdev","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/jpet.118.247668_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/sper.2002.37310","article-title":"The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit","volume":"26","author":"Guignard","year":"2002","journal-title":"Semin Perinatol"},{"key":"10.1124\/jpet.118.247668_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"113","author":"Haas","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib20","doi-asserted-by":"crossref","first-page":"505.e1","DOI":"10.1016\/j.ajog.2014.10.1091","article-title":"Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis","volume":"212","author":"Hammers","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajog.2004.11.009","article-title":"Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist","volume":"193","author":"Hirst","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2017.01.030","article-title":"Impact of G protein-coupled receptor heteromers in endocrine systems","volume":"449","author":"Jonas","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.118.247668_bib23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1517\/14656566.9.7.1153","article-title":"Developments in the pharmacotherapeutic management of spontaneous preterm labor","volume":"9","author":"Kam","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/jpet.118.247668_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fendo.2011.00002","article-title":"Biological significance of GPCR heteromerization in the neuro-endocrine system","volume":"2","author":"Kamal","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/jpet.118.247668_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/en.2013-1761","article-title":"EP2 receptor activates dual G protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium","volume":"155","author":"Kandola","year":"2014","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.118.247668_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal effects of prostaglandins and cyclooxygenase-2 inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electrolyte Blood Press"},{"issue":"Suppl 1","key":"10.1124\/jpet.118.247668_bib26","first-page":"245A","article-title":"Both OTR antagonists, atosiban and nolasiban, inhibit PGE2\/PGF2\u03b1-induced contractions of human pregnant myometrium in vitro","volume":"24","author":"Kim","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1124\/jpet.118.247668_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0952-3278(03)00113-3","article-title":"Expression of prostanoid receptors in human lower segment pregnant myometrium","volume":"69","author":"Leonhardt","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/jpet.118.247668_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1521-6934(03)00047-6","article-title":"Prostaglandin inhibitors in preterm labour","volume":"17","author":"Loudon","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1124\/jpet.118.247668_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.plefa.2003.04.004","article-title":"Expression, localization and function of prostaglandin receptors in myometrium","volume":"70","author":"Myatt","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/jpet.118.247668_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<282::AID-TERA7>3.0.CO;2-0","article-title":"Teratogen update: fetal effects of indomethacin administration during pregnancy","volume":"56","author":"Norton","year":"1997","journal-title":"Teratology"},{"key":"10.1124\/jpet.118.247668_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jsgi.2005.06.004","article-title":"The promise of prostaglandins: have they fulfilled their potential as therapeutic targets for the delay of preterm birth?","volume":"12","author":"Olson","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1124\/jpet.118.247668_bib32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2741\/2151","article-title":"Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour","volume":"12","author":"Olson","year":"2007","journal-title":"Front Biosci"},{"key":"10.1124\/jpet.118.247668_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/sper.2002.37307","article-title":"THG113: a novel selective FP antagonist that delays preterm labor","volume":"26","author":"Peri","year":"2002","journal-title":"Semin Perinatol"},{"key":"10.1124\/jpet.118.247668_bib34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0140-6736(99)03105-0","article-title":"Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic","volume":"354","author":"Peruzzi","year":"1999","journal-title":"Lancet"},{"key":"10.1124\/jpet.118.247668_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/oxfordjournals.ndt.a027470","article-title":"Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent","volume":"11","author":"Pomeranz","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.118.247668_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1203\/01.PDR.0000100904.17064.47","article-title":"Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit","volume":"55","author":"Pr\u00e9vot","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1124\/jpet.118.247668_bib37","doi-asserted-by":"crossref","first-page":"R1717","DOI":"10.1152\/ajpregu.00259.2006","article-title":"Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice","volume":"291","author":"Reese","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.118.247668_bib38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2003.255","article-title":"A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor","volume":"188","author":"Sawdy","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.118.247668_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/bbrc.1998.8461","article-title":"Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice","volume":"246","author":"Segi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.118.247668_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1993.tb12832.x","article-title":"In vitro characterization of prostanoid receptors on human myometrium at term pregnancy","volume":"108","author":"Senior","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.247668_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/107155760200900302","article-title":"Prostaglandins and prostanoid receptors in human pregnancy and parturition","volume":"9","author":"Slater","year":"2002","journal-title":"J Soc Gynecol Investig"},{"key":"10.1124\/jpet.118.247668_bib42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(02)11476-0","article-title":"Preterm delivery","volume":"360","author":"Slattery","year":"2002","journal-title":"Lancet"},{"key":"10.1124\/jpet.118.247668_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0031-6997(24)01348-6","article-title":"The pharmacology of the ductus arteriosus","volume":"50","author":"Smith","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.118.247668_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1126\/science.277.5326.681","article-title":"Failure of parturition in mice lacking the prostaglandin F receptor","volume":"277","author":"Sugimoto","year":"1997","journal-title":"Science"},{"key":"10.1124\/jpet.118.247668_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prostaglandins.2004.11.005","article-title":"Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats","volume":"79","author":"Toyoshima","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/jpet.118.247668_bib46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/molehr\/7.12.1187","article-title":"Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2\u03b1) and indomethacin","volume":"7","author":"Ulug","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"10.1124\/jpet.118.247668_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000415393","article-title":"Indomethacin as an inhibitor of preterm labor. Effect on postnatal renal function","volume":"67","author":"van der Heijden","year":"1988","journal-title":"Contrib Nephrol"},{"key":"10.1124\/jpet.118.247668_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCULATIONAHA.113.004726","article-title":"Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling","volume":"129","author":"Yokoyama","year":"2014","journal-title":"Circulation"},{"key":"10.1124\/jpet.118.247668_bib49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/molehr\/8.7.681","article-title":"Prostaglandin F(2\u03b1), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells","volume":"8","author":"Yoshida","year":"2002","journal-title":"Mol Hum Reprod"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.247668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:59:53Z","timestamp":1739995193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524262200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022356524262200"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.247668","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OBE022, an Oral and Selective Prostaglandin F2\u03b1 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.247668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}